BIOVAS trial seeking participants

In News by John Geddes

Vasculitis UK is helping the BIOVAS clinical trial to identify suitable participants.

The two-year trial is looking at the effectiveness of infliximab (INF), tocilizumab (TCZ) and rituximab (RTX).

Suitable patients will will have one of the following types of vasculitis:

  • Giant cell arteritis
  • Takayasu’s arteritis
  • Polyarteritis nodosa
    Cerebral vasculitis
  • Cogan’s syndrome
  • Relapsing polychondritis
  • IgA vasculitis
  • Non-infective cryoglobulinaemic vasculitis.

Patients will not be able to take part if they have recently received a biologic drug, have a serious infection, or are pregnant.

If you meet the specification and would be interested in taking part, please read the poster and full briefing, then discuss it with your doctor.